Microsoft Word - Eng-SET Q3-18 reviewed Ref: FASET 04/2561 November 12, 2018 Subject: Report the operating result for the third quarter and for the nine-month period ended September 30, 2018 To
ที่ กบร No. Lor Gor. 005/2020 May 14, 2020 President The Stock Exchange of Thailand Re : Clarification on the company’s over 20% change in its operating results for 1st quarter, 2020 Dear Sir, Thai
Our Ref: APURE 027/2020 13 August 2020 Subject Clarification on Second Quarter’s Operating Performance (2/2020) Attn. To President The Stock Exchange of Thailand The company clarifies causes and
Our Ref: APURE 017/2021 14 May 2021 Subject Clarification on First Quarter’s Operating Performance (1/2021) Attn. To The Director and President of the Stock Exchange of Thailand The company clarifies
Our Ref: APURE 017/2022 13 May 2022 Subject Clarification on First Quarter’s Operating Performance (1/2022) Attn. To The Director and President of the Stock Exchange of Thailand The company clarifies
Our Ref: APURE 025/2023 15 August 2023 Subject Clarification on Second Quarter’s Operating Performance (2/2023) Attn. To The Director and President of the Stock Exchange of Thailand The company
. 3. Performance of the Company Operating Results The Company reported a net profit of Baht 3,345 million compared to loss of Baht 1,810 million last year as explained above. The consolidated post net
medical service concerning health and esthetics. 2. Overview of operating results in 3 quarters of 2019. Continued from the first Quarter of 2019 until third Quarter, the world economic still be tense from
languages, the Thai version shall prevail. The objective of this MD&A is to present the information and the explanation of financial status and operating results as of the date hereof. However, the